Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - sodium acetate trihydrate 2,5 g/1026 ml - eq. sodium acetate 1,5 g/1026 ml; sodium glycerophosphate hydrate - eq. sodium glycerophosphate 1,48 mg/ml; glycine 2,3 mg/ml; glutamic acid 1,64 mg/ml; valine 2,14 mg/ml; arginine 3,31 mg/ml; lysine hydrochloride 3,31 mg/ml - eq. lysine 2,65 mg/ml; leucine 2,3 mg/ml; potassium chloride 1,75 mg/ml; serine 1,33 mg/ml; proline 1,99 mg/ml; alanine 4,68 mg/ml; histidine 1,99 mg/ml; threonine 1,64 mg/ml; tryptophan 0,55 mg/ml; soya oil 38,97 mg/ml; aspartic acid 1,01 mg/ml; glucose monohydrate 107,17 mg/ml - eq. glucose anhydrous 97,43 g/l; calcium chloride dihydrate 0,29 g/1026 ml - eq. calcium chloride 0,22 g/1026 ml; tyrosine 66,25 µg/ml; isoleucine 1,64 mg/ml; methionine 1,64 mg/ml; phenylalanine 2,3 mg/ml; magnesium sulfate 0,47 mg/ml - emulsion for infusion - combinations

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - sodium acetate trihydrate 2,5 g/1026 ml - eq. sodium acetate 1,5 g/1026 ml; sodium glycerophosphate hydrate - eq. sodium glycerophosphate 1,48 mg/ml; glycine 2,3 mg/ml; glutamic acid 1,64 mg/ml; valine 2,14 mg/ml; arginine 3,31 mg/ml; lysine hydrochloride 3,31 mg/ml - eq. lysine 2,65 mg/ml; leucine 2,3 mg/ml; potassium chloride 1,75 mg/ml; serine 1,33 mg/ml; proline 1,99 mg/ml; alanine 4,68 mg/ml; histidine 1,99 mg/ml; threonine 1,64 mg/ml; tryptophan 0,55 mg/ml; soya oil 38,97 mg/ml; aspartic acid 1,01 mg/ml; glucose monohydrate 107,17 mg/ml - eq. glucose anhydrous 97,43 g/l; calcium chloride dihydrate 0,29 g/1026 ml - eq. calcium chloride 0,22 g/1026 ml; tyrosine 66,25 µg/ml; isoleucine 1,64 mg/ml; methionine 1,64 mg/ml; phenylalanine 2,3 mg/ml; magnesium sulfate 0,47 mg/ml - emulsion for infusion - combinations

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - sodium acetate trihydrate 2,5 g/1026 ml - eq. sodium acetate 1,5 g/1026 ml; sodium glycerophosphate hydrate - eq. sodium glycerophosphate 1,48 mg/ml; glycine 2,3 mg/ml; glutamic acid 1,64 mg/ml; valine 2,14 mg/ml; arginine 3,31 mg/ml; lysine hydrochloride 3,31 mg/ml - eq. lysine 2,65 mg/ml; leucine 2,3 mg/ml; potassium chloride 1,75 mg/ml; serine 1,33 mg/ml; proline 1,99 mg/ml; alanine 4,68 mg/ml; histidine 1,99 mg/ml; threonine 1,64 mg/ml; tryptophan 0,55 mg/ml; soya oil 38,97 mg/ml; aspartic acid 1,01 mg/ml; glucose monohydrate 107,17 mg/ml - eq. glucose anhydrous 97,43 g/l; calcium chloride dihydrate 0,29 g/1026 ml - eq. calcium chloride 0,22 g/1026 ml; tyrosine 66,25 µg/ml; isoleucine 1,64 mg/ml; methionine 1,64 mg/ml; phenylalanine 2,3 mg/ml; magnesium sulfate 0,47 mg/ml - emulsion for infusion - combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - cannabidiol, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sesame oil; sucralose; ethanol absolute; flavour - epidyolex is indicated for use as adjunctive therapy of seizures associated with lennox-gastaut syndrome (lgs) or dravet syndrome (ds) for patients 2 years of age and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine,arginine,aspartic acid,calcium chloride dihydrate,glucose monohydrate,glutamic acid,glycine,histidine,isoleucine,leucine,lysine hydrochloride,magnesium sulfate heptahydrate,methionine,phenylalanine,potassium chloride,proline,serine,sodium acetate trihydrate,sodium glycerophosphate,soya oil,threonine,tryptophan,tyrosine,valine -

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - fluconazole - solution for infusion - 2 mg/ml - triazole derivatives

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - fluconazole 2 mg/ml (polymorph form iii) - solution for infusion - 2 mg/ml - active: fluconazole 2 mg/ml (polymorph form iii) excipient: sodium chloride water for injection - · cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary, cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. fluconazole injection usp can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids.

New Zealand - English - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - ipilimumab 5 mg/ml;   - concentrate for injection - 200 mg/40 ml - active: ipilimumab 5 mg/ml   excipient: hydrochloric acid mannitol nitrogen pentetic acid polysorbate 80 sodium chloride sodium hydroxide trometamol hydrochloride water for injection - yervoy, as monotherapy, is indicated for the treatment of patients with unresectable or metastatic melanoma in adults, 18 years of age or older. yervoy, in combination with opdivo (ipilimumab), is indicated for the treatment of patients with unresectable or metastatic disease melanoma.

New Zealand - English - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - ipilimumab 5 mg/ml;   - concentrate for injection - 50 mg/10 ml - active: ipilimumab 5 mg/ml   excipient: hydrochloric acid mannitol nitrogen pentetic acid polysorbate 80 sodium chloride sodium hydroxide trometamol hydrochloride water for injection - yervoy, as monotherapy, is indicated for the treatment of patients with unresectable or metastatic melanoma in adults, 18 years of age or older. yervoy, in combination with opdivo (ipilimumab), is indicated for the treatment of patients with unresectable or metastatic disease melanoma.

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - fluconazole - solution for infusion - 2 mg/ml - triazole derivatives